FONDATION DE COOPERATION SCIENTIFIQUE MALADIE D'ALZHEIMER ET MALADIES APPARENTEES

Their core work

Fondation Alzheimer is a French scientific cooperation foundation dedicated to Alzheimer's disease and related neurodegenerative disorders. Their core work within H2020 has focused on coordinating and sustaining the Joint Programming Initiative on Neurodegenerative Diseases (JPND) — aligning national research strategies across Europe, mapping research capacities, and enabling transnational collaboration. They serve as a policy and coordination backbone for neurodegenerative disease research rather than conducting laboratory research directly.

What they specialise in

How they've shifted over time

All three projects fall within a narrow window (2015–2024) and share a common thread: the JPND initiative. The earlier projects (JPco-fuND and JPsustaiND, both starting 2015) focused on establishing synergies and ensuring the sustainability of joint programming structures. The most recent project (JPCOFUND2, 2019) shifts toward operationalizing the JPND strategic plan with an emphasis on personalised diagnosis, prevention, and care — suggesting a move from coordination infrastructure toward applied research priorities.

Moving from building coordination infrastructure toward funding and enabling personalised medicine approaches in neurodegenerative disease — a partner increasingly relevant for precision health initiatives.

How they like to work

Fondation Alzheimer participates exclusively as a partner, never as coordinator, consistent with their role as a national foundation contributing to pan-European coordination structures. With 42 unique partners across 27 countries from just 3 projects, they operate in very large consortia typical of ERA-NET and CSA instruments. This wide network signals strong institutional connectivity — they are a hub connecting many national research funders and policy bodies across Europe.

Remarkably broad network for a small project portfolio: 42 unique partners across 27 countries, reflecting their role in pan-European joint programming where most EU and associated country research funders participate. Their reach is essentially continent-wide.

What sets them apart

Fondation Alzheimer occupies a specific niche as France's dedicated scientific cooperation foundation for Alzheimer's and related diseases, giving it a national mandate that few other organizations hold. Within H2020, they are deeply embedded in the JPND architecture — the main European mechanism for aligning neurodegenerative disease research across borders. For consortium builders in dementia or neurodegeneration, they offer a direct bridge to French national research funding and policy alignment.

Highlights from their portfolio

• JPsustaiND
  Largest funding (EUR 270,938) and most keyword-rich project, focused on sustaining and globalising the entire JPND initiative — a backbone coordination action.
• JPCOFUND2
  Most recent project (2019-2024) marking a strategic shift toward personalised diagnosis, prevention, and care in neurodegenerative diseases.